Purnanand D. Sarma

Purnanand D. Sarma

Ph.D. (9) Former Chief Executive OfficeratImmunome· In proxies 2022–2023

Pay in FY2022Immunome stock -82.9% the same year

Purnanand D. Sarma was paid $990.3K in FY2022 (Dec). Immunome stock fell 82.9% that year.

Pay$100 in the stock at the end of FY21 → $17
Pay is from the Summary Compensation Table of each Immunome proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ImmunomePublic company · 4 yr
    • Ph.D. (9) Former Chief Executive Officer2022 – Present · 4 yrStock in role +17%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?